Anti-GalNAc-GD1a antibody-associated Guillain-Barre syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance

Annals of Neurology

Volumn 45, Issue 6, 1999, Pages 758-768

  Hao, Qi ^a   Saida, Takahiko ^a   Yoshino, Hiide ^b   Kuroki, Shigekazu ^c   Nukina, Masafumi ^d   Saida, Kyoko ^a,e  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b 1 7 1 Kohnodai   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d Public Health Research Institute of Kobe City   (Japan)

^e Nishinara National Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; N ACETYLGALACTOSAMINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL NERVE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MOTOR NERVE CONDUCTION; MUSCLE WEAKNESS; NERVE INJURY; PRIORITY JOURNAL; SENSORY DYSFUNCTION;

ACETYLGALACTOSAMINE; ADULT; AGE DISTRIBUTION; AUTOANTIBODIES; CRANIAL NERVE DISEASES; CRANIAL NERVES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M1) GANGLIOSIDE; HUMANS; MALE; POLYRADICULONEUROPATHY; SEX DISTRIBUTION;

EID: 0033050651     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199906)45:6<758::AID-ANA10>3.0.CO;2-N     Document Type: Article

References (34)

1. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J 1984;288:1867-1870
2. Winer JB, Hughes RAC, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-618
3. Boucquey D, Sindic CJM, Lamy M, Delmee M. Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J Neurol Sci 1991;104:56-63
4. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991;34:43-51
5. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
6. Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-117
7. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol 1993;33:243-247
8. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-953
9. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34: 130-135
10. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379
11. Hao Q, Saida T, Kuroki S, et al. Antibodies to gangliosides and galactocerebtoside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 1998;81:116-126
12. Arnason BGW, Soliven B. Acute inflammatory demyelinating polyradiculoneuropathies. In: Dyck PJ, Tohomas PK, Griffin JW, eds. Peripheral neuropathy. 3rd ed. Philadelphia: WB Saunders, 1993:1437-1446
13. Ilyas AA, Mithen FA, Chen ZW, Cood SD. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J Neuroimmunol 1992; 36:69-76
14. Nobile-Orazio E, Carpo M, Meucci N, et al. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 1992;109:200-206
15. Simone LL, Annuziata P, Maimone D, et al. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1993;114:49-55
16. van den Berg LH, Marrink J, de Jager AEJ, et al. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1993;55:8-11
17. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679
18. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902
19. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816
20. Jacobs BC, Van Doom PA, Schmitz PIM, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-187
21. Visser LH, Van Der Meché FGA, Van Doom PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-847
22. Kuwabara S, Yuki N, Koga M, et al. IgG antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44:202-208
23. Kusunoki S, Chiba A, Kon K, et al. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576
24. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990; 27(Suppl):S21-S24
25. Ho TW, Li CY, Cornblath DR, et al. Patterns of recovery in the Guillain-Barré syndromes. Neurology 1997;48:695-700
26. Hirabayayashi Y, Suzuki T, Suzuki Y, et al. A new method for purification of anti-glycosphingolipid antibody: avian anti-hematoside (NeuGc) antibody. J Biochem 1983;94:327-330
27. Kuroki S, Haruta T, Yoshioka M, et al. Guillain-Barré syndrome associated with Campylobacter infection. Pediatr Infect Dis J 1991;10:149-151
28. Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;12:732-737
29. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342
30. Ilyas AA, Li SC, Chou DKH, et al. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGD1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J Biol Chem 1988;263:4369-4373
31. Yoshino H. Distribution of gangliosides in the nervous tissues recognized by axonal form of Guillain-Barré syndrome [in Japanese]. Neuroimmunology 1997;5:174-175
32. Kusunoki S, Chiba A, Tai T, Kanazawa I. Localization of GM1 and GDIa antigens in the human peripheral nervous system. Muscle Nerve 1993;16:752-756
33. Hirota N, Kaji R, Bostock H, et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997;120:2159-2169
34. Yuki N, Taki T, Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 1996;71:155-161